Quoin Pharmaceuticals is into developing products which address major unmet medical needs.
Quoin Pharmaceuticals has raised $104.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Quoin Pharmaceuticals's investors include Soleus Capital, ADAR1 Capital Management, Nantahala Capital Management, Velan Capital, AIGH Capital Management.
Quoin Pharmaceuticals is headquartered in Ashburn, United States.
Quoin Pharmaceuticals is into developing products which address major unmet medical needs.
Quoin Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quoin Pharmaceuticals — Funding & Investors." VCBacked, October 10, 2025, https://www.vcbacked.co/company/quoin-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2025). Quoin Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/quoin-pharmaceuticals
{{cite web |title=Quoin Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/quoin-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated